Finally, chemerin’s involvement in diabetic cardiomyopathy has been demonstrated through its role in the chemerin/CMKLR1 axis, which contributes to inflammation, hypertrophy, proptosis, and fibrosis in the heart tissue of DBCM rats, primarily via NLRP3 inflammasome activation [91]. Here, RARRES2 is linked to diabetic cardiomyopathy.